Waters Corporation Completes Combination with BD's Biosciences and Diagnostic Solutions Businesses

Waters Corporation Acquires Halo Labs

May 21, 2025

Medical Devices

Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.

BD Acquires Edwards Lifesciences' Critical Care Product Group

September 3, 2024

Medical Devices

BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group and has renamed the business BD Advanced Patient Monitoring, based in Irvine, California. The deal expands BD's smart connected care portfolio with advanced monitoring technologies and AI-enabled clinical decision tools, and aligns the new unit within BD's Medical segment to enable integration with BD's infusion platforms and future closed-loop monitoring innovations.

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.

MJH Life Sciences Acquires BPD Healthcare

October 22, 2025

Marketing & Advertising

MJH Life Sciences has acquired BPD Healthcare, a tech-enabled marketing and communications partner for health systems and healthcare innovators. The acquisition, completed Oct. 22, 2025 with terms undisclosed, expands MJH's capabilities in data-driven marketing, communications and strategic advisory services; WindRose Health Investors sold its stake in BPD.

Waters Corporation Acquires Wyatt Technology

February 15, 2023

Medical Devices

Waters Corporation agreed to acquire Wyatt Technology, a leader in light scattering instruments, software and related services, for $1.36 billion in cash. The acquisition (expected to close in Q2 2023) expands Waters' capabilities and exposure to bioanalytical characterization and large-molecule applications; Wyatt reported ~ $110 million in 2022 revenue and employs more than 200 people worldwide.

Covanta Acquires BIOLOGIC Environmental Services and Waste Solutions

August 29, 2022

Environmental Services

Covanta has acquired BIOLOGIC Environmental Services and Waste Solutions, a California-based regulated waste management firm, and will integrate Biologic's Northern and Southern California facilities into its portfolio. The deal expands Covanta's western U.S. footprint and adds regulated/medical and maritime waste handling capabilities to support its sustainable materials management strategy.